COGNITIVE APPRAISAL. AN EXAMINATION = EVALUATION COGNITIVE: UNE ANALYSEFISHER RI.1974; J. PSYCHOL.; U.S.A.; DA. 1974; VOL. 88; NO 2; PP. 147-152; BIBL. 3REF.Article

ADVANCES IN THE STAGING AND TREATMENT OF OVARIAN CANCER.FISHER RI; YOUNG RC.1977; CANCER; U.S.A.; DA. 1977; VOL. 39; NO 2 SUPPL.; PP. 967-972; BIBL. 31 REF.; (AM. CANCER SOC. NATL. CONF. RADIAT. ONCOL. PRESENT STATUS FUTURE POTENTIAL. PROC.; SAN FRANCISCO, CALIF.; 1976)Conference Paper

THE STAGING AND TREATMENT OF EPITHELIAL OVARIAN CANCERYOUNG RC; FISHER RI.1978; CANAD. MED. ASS. J.; CAN; DA. 1978; VOL. 119; NO 3; PP. 249-256; (6 P.); ABS. FRE; BIBL. 34 REF.Article

CHARACTERIZATION OF THE LYMPHOCYTE SURFACE RECEPTORS FOR CON A AND PHAHENKART PA; FISHER RI.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 2 PART. 1; PP. 710-714; BIBL. 29REF.Article

INCREASED SENSITIVITY OF T CELLS TO REGULATION BY NORMAL SUPPRESSOR CELLS PERSISTS IN LONG-TERM SURVIVORS WITH HODGKIN'S DISEASEVANHAELEN CPJ; FISHER RI.1982; AM. J. MED.; ISSN 0002-9343; USA; DA. 1982; VOL. 72; NO 3; PP. 385-390; BIBL. 21 REF.Article

REQUIREMENTS FOR SUCCESSFUL IMMUNOTHERAPY AND CHEMOIMMUNOTHERAPY OF A MURINE MODEL OF OVARIAN CANCERVANHAELEN CPJ; FISHER RI.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 3; PP. 980-983; BIBL. 20 REF.Article

DEPRESSED T CELL PROLIFERATIVE RESPONSES IN HODGKIN'S DISEASE: ROLE OF MONOCYTE-MEDIATED SUPPRESSION VIA PROSTAGLANDINS AND HYDROGEN PEROXIDEFISHER RI; BOSTICK BRUTON F.1982; JOURNAL OF IMMUNOLOGY; ISSN 0022-1767; USA; DA. 1982; VOL. 129; NO 4; PP. 1770-1774; BIBL. 31 REF.Article

INCREASED SENSITIVITY OF LYMPHOCYTES FROM PATIENTS WITH HODGKIN'S DISEASE TO CONCANAVALIN A-INDUCED SUPPRESSOR CELLSVAN HAELEN CPJ; FISHER RI.1981; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1981; VOL. 127; NO 3; PP. 1216-1220; BIBL. 33 REF.Article

PHASE II STUDY OF HIGH-DOSE METHOTREXATE IN PATIENTS WITH ADVANCED MALIGNANT MELANOMAFISHER RI; CHABNER BA; MYERS CE et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 1; PP. 147-148; BIBL. 6 REF.Article

OESTROGEN RECEPTORS IN HUMAN MALIGNANT MELANOMA.FISHER RI; NEIFELD JP; LIPPMAN ME et al.1976; LANCET; G.B.; DA. 1976; NO 7981; PP. 337-338; BIBL. 21 REF.Article

PERITONEOSCOPY IN THE MANAGEMENT OF OVARIAN CANCEROZOLS RF; FISHER RI; ANDERSON T et al.1981; AM. J. OBSTET. GYNECOL.; ISSN 0002-9378; USA; DA. 1981; VOL. 140; NO 6; PP. 611-619; BIBL. 16 REF.Article

OVARIAN CANCER: A SOLID TUMOR WITH EVIDENCE OF NORMAL CELLULAR IMMUNE FUNCTION BUT ABNORMAL B CELL FUNCTIONMANDELL GL; FISHER RI; BOSTICK F et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 66; NO 4; PP. 621-624; BIBL. 20 REF.Article

REGRESSION OF A T-CELL LYMPHOMA AFTER ADMINISTRATION OF ANTITHYMOCYTE GLOBULIN.FISHER RI; KUBOTA TT; MANDELL GL et al.1978; ANN. INTERN. MED.; USA; DA. 1978; VOL. 88; NO 6; PP. 799-800; BIBL. 12 REF.Article

DIFFUSE HISTIOCYTIC LYMPHOMA INVOLVING THE GASTROINTESTINAL TRACT.HANDE KR; FISHER RI; DEVITA VT et al.1978; CANCER; U.S.A.; DA. 1978; VOL. 41; NO 5; PP. 1984-1989; BIBL. 27 REF.Article

IMMUNOBLASTIC LYMPHADENOPATHY. EVOLUTION INTO A MALIGNANT LYMPHOMA WITH PLASMACYTOID FEATURES.FISHER RI; JAFFE ES; BRAYLAN RC et al.1976; AMER. J. MED.; U.S.A.; DA. 1976; VOL. 61; NO 4; PP. 553-559; BIBL. 22 REF.Article

STAGING OF NON-HODGKIN'S LYMPHOMACHABNER BA; FISHER RI; YOUNG RC et al.1980; SEMIN. ONCOL.; ISSN 0093-7754; USA; DA. 1980; VOL. 7; NO 3; PP. 285-291; BIBL. 21 REF.Article

OBJECTIVE REGRESSIONS OF T- AND B-CELL LYMPHOMAS IN PATIENTS FOLLOWING TREATMENT WITH ANTI-THYMOCYTE GLOBULINFISHER RI; SILVER BA; VANHAELEN CP et al.1982; CANCER RES.; ISSN 0008-5472; USA; DA. 1982; VOL. 42; NO 6; PP. 2465-2469; BIBL. 13 REF.Article

REDUCED CONCENTRATIONS OF THE FIRST COMPONENT OF COMPLEMENT IN HYPOGAMMAGLOBULINEMIA: CORRECTION BY INFUSION OF GAMMA -GLOBULIN.ATKINSON JP; FISHER RI; REINHARDT R et al.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1978; VOL. 9; NO 3; PP. 350-355; BIBL. 28 REF.Article

PERCUTANEOUS ASPIRATION OF RETROPERITONEAL LYMPH NODES IN OVARIAN CANCERDUNNICK NR; FISHER RI; CHU EW et al.1980; AMER. J. ROENTGENOL.; USA; DA. 1980; VOL. 135; NO 1; PP. 109-113; BIBL. 15 REF.Article

KINETIC CHARACTERIZATION AND REPONSE TO CHEMOTHERAPY IN A TRANSPLANTABLE MURINE OVARIAN CANCEROZOLS RF; GROTZINGER KR; FISHER RI et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 8; PP. 3202-3208; BIBL. 27 REF.Article

ACTIVITY OF THE EPIPODOPHYLLOTOXIN VP-16 IN THE TREATMENT OF COMBINATION CHEMOTHERAPY-RESISTANT NON-HODGKIN LYMPHOMABENDER RA; ANDERSON T; FISHER RI et al.1978; AMER. J. HEMATOL.; USA; DA. 1978; VOL. 5; NO 3; PP. 203-209; BIBL. 14 REF.Article

PHASE II TRIAL OF CHLOROZOTOCIN IN MALIGNANT MELANOMA, BREAST CANCER, AND OTHER SOLID TUMORSSILVER BA; BARLOCK AL; LIPPMAN ME et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 5; PP. 1229-1230; BIBL. 14 REF.Article

LACK OF HISTOCOMPATIBILITY ANTIGENS ON A MURINE OVARIAN TERATOCARCINOMAVANHAELEN CPJ; FISHER RI; APPELLA E et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 8; PP. 3186-3191; BIBL. 28 REF.Article

A PROSPECTIVE RANDOMIZED STUDY OF ADJUVANT PARENTERAL NUTRITION IN THE TREATMENT OF ADVANCED DIFFUSE LYMPHOMA: INFLUENCE ON SURVIVALPOPP MB; FISHER RI; WESLEY R et al.1981; SURGERY; ISSN 0039-6060; USA; DA. 1981; VOL. 90; NO 2; PP. 195-203; BIBL. 25 REF.Article

CHLOROZOTOCIN, AN ANTI-TUMOUR AGENT LACKING BONE MARROW TOXICITY AT THERAPEUTIC DORES: EFFECTS ON LYMPHOCYTE SUBPOPULATIONS IN MICEFISHER RI; MANDELL GL; BOSTICK F et al.1980; CLIN. EXPER. IMMUNOL.; GBR; DA. 1980; VOL. 39; NO 2; PP. 416-425; BIBL. 18 REF.Article